Newsroom

Portrait Berit Lange
News
Federal Chancellor Olaf Scholz today welcomed the members of the new Expert Council on Health and Resilience to the inaugural meeting at the Federal Chancellery. Among the members is Dr. Berit Lange, Acting Head of the Department of Epidemiology and Head of Clinical Epidemiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig.
18.03.2024
Christian Scherf, Josef Penninger, Berit Lange, Christos Pantazis
News
On March 14, 2024, representatives of the Helmholtz Centre for Infection Research (HZI) and the Helmholtz Association met with around 30 members of the Bundestag in Berlin. Prof. Josef Penninger, Scientific Director of the HZI, and Dr. Berit Lange, Acting Head of the HZI Department of Epidemiology, presented the current state of research on pandemic resilience at a parliamentary breakfast entitled "Mastering pandemics: Focus on resilience, innovation and cutting-edge international research". The patron of the event was Dr. Christos Pantazis, Member of the German Bundestag.
15.03.2024
Electron micrograph of Pseudomonas aeruginosa
News
Pseudomonas aeruginosa is an important opportunistic pathogen responsible for life-threatening infections that are associated with high rates of morbidity and mortality. Researchers from TWINCORE, the Centre for Experimental and Clinical Infection Research in Hannover, and the Helmholtz Centre for Infection Research (HZI) in Braunschweig have now been able to show that an enzyme controls virulence through modification of tRNAs.
14.03.2024
Portrait Tobias Welte
News
On March 10, 2024, Prof. Tobias Welte, Director of the Clinic for Pneumology and Infectiology at Hannover Medical School (MHH), passed away unexpectedly at the age of 64. Welte was a long-standing close cooperation partner in joint research projects between the Helmholtz Centre for Infection Research (HZI) and the MHH, which resulted in numerous publications in renowned research journals.
12.03.2024
[Translate to English:] Portrait Thekla Cordes
News
Despite modern immunotherapies and existing drugs, lung cancer patients often develop resistance to treatment. To close this gap, an international team including Thekla Cordes, professor for cell metabolism at Technische Universität Braunschweig at the Braunschweig Centre for Systems Biology (BRICS) and head of the research group “Cellular Metabolism in Infection” at the Helmholtz Centre for Infection Research (HZI), as well as researchers from the Salk Institute for Biological Studies (USA) and Yale University School (USA), investigated potential targets for cancer therapies. Their results have been published in the journal Cancer Discovery.
08.03.2024
Prof Anna Hirsch and Dr Walid Elgaher sit in front of a laptop
News
New active substances for the treatment of resistant bacteria are needed more urgently than ever – yet only few candidates make the leap from research to clinical application. To facilitate precisely this transition, the US organization CARB-X provides targeted funding for advanced projects in antibiotics research. Saarbrücken researcher Anna Hirsch has now successfully acquired CARB-X funding for one of her innovative projects for the second time. The aim of the project, which is funded with up to 1.25 million US dollars, is to develop resistance-breaking antibiotics for the treatment of bacterial pneumonia.
04.03.2024

HZI in the media

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025
|
Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025
|
Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025
|
AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025
|
Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025
|
Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025
|
Apotheken Umschau

... am 1. Oktober 2025. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

07.10.2025
|
juraforum.de

... „Epidemiologie und Ökologie antimikrobieller Resistenz“ am HZI-Standort Helmholtz-Institut für One Health (HIOH), am Projekt ...

06.10.2025
|
Bochumer-Zeitung

” says Mark Brönstrup, a professor at both the Helmholtz Center for Infection Research and Leibniz University Hannover, who wasn’t involved

04.10.2025
|
MIT CSAIL

... Hannover (MHH) und Klinischer Direktor des Helmholtz-Zentrums für Infektionsforschung (HZI). Auch an der Gründung des ...

03.10.2025
|
Deutsches Ärzteblatt

... des Sensormoleküls

 

Prof. Carlos A. Guzmán (Helmholtz-Zentrum für Infektionsforschung, Braunschweig) mit den Teams um Dr. ...

02.10.2025
|
Medizin Aspekte

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025
|
Die heutigen Nachrichten

Register now for the HZI-Newsletter